Baidu
map

Cell:热休克诱发细胞内蛋白质聚集的分子机理

2015-09-16 佚名 生物谷

当细胞暴露于较高非致死性的温度下时,细胞内的蛋白质聚集体就会形成,这似乎是对压力产生反应的一种表现形式,但损伤蛋白的积累似乎并不会在形成过程中被破坏;近日刊登在国际杂志Cell上的一项研究论文中,来自芝加哥大学和哈佛大学的研究人员通过研究发现,当细胞回归到正常温度下时,这种蛋白聚集可以被完全逆转恢复,聚集的蛋白质会被解开重新恢复其正常的功能,本文研究为揭示蛋白质聚集的生物学本质提供了新的思路。尽管

当细胞暴露于较高非致死性的温度下时,细胞内的蛋白质聚集体就会形成,这似乎是对压力产生反应的一种表现形式,但损伤蛋白的积累似乎并不会在形成过程中被破坏;近日刊登在国际杂志Cell上的一项研究论文中,来自芝加哥大学和哈佛大学的研究人员通过研究发现,当细胞回归到正常温度下时,这种蛋白聚集可以被完全逆转恢复,聚集的蛋白质会被解开重新恢复其正常的功能,本文研究为揭示蛋白质聚集的生物学本质提供了新的思路。

尽管研究者们进行了很多年的研究,但他们似乎都不能解释为何细胞会对热休克产生反应,当细胞暴露于压力条件下时,某些细胞蛋白就会聚集形成名为应激颗粒(stress granules)的大块结构;对突变细胞系的研究表明,特殊类型的应激颗粒可以被细胞及其蛋白组分的重新恢复而破坏。为了深入研究热休克对天然蛋白群体的影响,研究者Drummond及其同事利用一种新型技术设备同时追踪了计划1000种不同的酵母细胞成熟蛋白质,研究小组将细胞暴露于30度(正常)至46度(严重热休克状态)之间,暴露时间2-8分钟,随后利用质谱法等工具测定了细胞内蛋白质的聚集情况。

随后研究者鉴别出了对热休克产生反应聚集的超过175种不同的蛋白质,大约有六分之一的蛋白质被进行了测定,而且是之前测定的10倍;特殊的蛋白质可以在特殊及分离的细胞位置形成应激颗粒,然而研究小组还发现,在很多情况下蛋白聚集会发生,但应激颗粒却不会产生,这就表明蛋白聚集和应激颗粒的形成具有相关性,但彼此缺失独立的过程。

基于此前的研究基础,研究者推测表示,在热休克过程蛋白质聚集的主要目的就是对细胞工厂重新改造,重点关注于压力过程中蛋白质的合成系统;在某些情况下蛋白质可以扮演自发的温度计和调节器,去感知温度以及进行自我组装来激活或失活某些细胞功能。Edward Wallace博士指出,热诱导的蛋白质聚集或许是适应性反应的一个标志,我们的研究从细胞器层面上阐明了这一点。

同时本文研究也提出了一些引人入胜的问题,比如蛋白质聚集的本质是什么?而且蛋白质聚集如何在多种神经变性疾病中发生的?目前研究人员正在努力研究来解释蛋白质聚集的生物学功能,尤其是其在细胞功能中的调节子的角色是如何扮演的,未来研究者还将通过更多研究来阐明蛋白质聚集发生的机制,或将为开发抵御人类疾病的新型疗法提供帮助。

原文出处:

Edward W.J. Wallace,et al.Reversible, Specific, Active Aggregates of Endogenous Proteins Assemble upon Heat Stress.cell.2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1869215, encodeId=8dc8186921559, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Sep 30 04:14:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765558, encodeId=9f821e655582d, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jul 31 16:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922344, encodeId=c24c192234400, content=<a href='/topic/show?id=768d316206c' target=_blank style='color:#2F92EE;'>#分子机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31620, encryptionId=768d316206c, topicName=分子机理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Dec 31 15:14:00 CST 2015, time=2015-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959470, encodeId=f35419594e08d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Oct 14 01:14:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296917, encodeId=6fa0129691e91, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 18 00:14:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1869215, encodeId=8dc8186921559, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Sep 30 04:14:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765558, encodeId=9f821e655582d, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jul 31 16:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922344, encodeId=c24c192234400, content=<a href='/topic/show?id=768d316206c' target=_blank style='color:#2F92EE;'>#分子机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31620, encryptionId=768d316206c, topicName=分子机理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Dec 31 15:14:00 CST 2015, time=2015-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959470, encodeId=f35419594e08d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Oct 14 01:14:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296917, encodeId=6fa0129691e91, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 18 00:14:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1869215, encodeId=8dc8186921559, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Sep 30 04:14:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765558, encodeId=9f821e655582d, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jul 31 16:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922344, encodeId=c24c192234400, content=<a href='/topic/show?id=768d316206c' target=_blank style='color:#2F92EE;'>#分子机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31620, encryptionId=768d316206c, topicName=分子机理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Dec 31 15:14:00 CST 2015, time=2015-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959470, encodeId=f35419594e08d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Oct 14 01:14:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296917, encodeId=6fa0129691e91, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 18 00:14:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1869215, encodeId=8dc8186921559, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Sep 30 04:14:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765558, encodeId=9f821e655582d, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jul 31 16:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922344, encodeId=c24c192234400, content=<a href='/topic/show?id=768d316206c' target=_blank style='color:#2F92EE;'>#分子机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31620, encryptionId=768d316206c, topicName=分子机理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Dec 31 15:14:00 CST 2015, time=2015-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959470, encodeId=f35419594e08d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Oct 14 01:14:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296917, encodeId=6fa0129691e91, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 18 00:14:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]
    2015-10-14 智智灵药
  5. [GetPortalCommentsPageByObjectIdResponse(id=1869215, encodeId=8dc8186921559, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Sep 30 04:14:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765558, encodeId=9f821e655582d, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jul 31 16:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922344, encodeId=c24c192234400, content=<a href='/topic/show?id=768d316206c' target=_blank style='color:#2F92EE;'>#分子机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31620, encryptionId=768d316206c, topicName=分子机理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Thu Dec 31 15:14:00 CST 2015, time=2015-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959470, encodeId=f35419594e08d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Oct 14 01:14:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296917, encodeId=6fa0129691e91, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Sep 18 00:14:00 CST 2015, time=2015-09-18, status=1, ipAttribution=)]

相关资讯

gp96抗乙肝病毒功能研究获进展

来源:中科院微生物研究所   热休克蛋白gp96(又称GRP94)是位于细胞内质网膜上的热休克蛋白90家族中的一员,在天然免疫和获得性免疫中发挥着重要作用。gp96能作为分子伴侣结合细胞中的肿瘤抗原、病毒抗原或胞内细菌抗原,并将结合的抗原表位呈递给抗原递呈细胞的“专用运输车”MHC I类和II类分子,从而启动特异性T细胞CD8+和CD4+T细胞免疫应答。另一方面,gp96分子本身作为免

Baidu
map
Baidu
map
Baidu
map